These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 38844739)

  • 1. Dynamic change of gut microbiota in head and neck concurrent chemoradiotherapy patients and its potential value in the prediction of acute oral mucositis grade as well as quality of life.
    Chen Y; Ye X; Li X; Wang F; Yang J; Sun X; Yan S
    Clin Transl Oncol; 2024 Jun; ():. PubMed ID: 38844739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Analysis of the dynamic changes in gut microbiota in patients with extremely severe burns by 16S ribosomal RNA high-throughput sequencing technology].
    Pan YY; Fan YF; Li JL; Cui SY; Huang N; Jin GY; Chen C; Zhang C
    Zhonghua Shao Shang Za Zhi; 2020 Dec; 36(12):1159-1166. PubMed ID: 33379852
    [No Abstract]   [Full Text] [Related]  

  • 3. Baseline gut microbiota composition is associated with oral mucositis and tumour recurrence in patients with head and neck cancer: a pilot study.
    Al-Qadami G; Bowen J; Van Sebille Y; Secombe K; Dorraki M; Verjans J; Wardill H; Le H
    Support Care Cancer; 2023 Jan; 31(1):98. PubMed ID: 36607434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An insight into the commercial piglet's microbial gut colonization: from birth towards weaning.
    Saladrigas-García M; Durán M; D'Angelo M; Coma J; Pérez JF; Martín-Orúe SM
    Anim Microbiome; 2022 Dec; 4(1):68. PubMed ID: 36572944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gut Microbiota Characteristics Are Associated With Severity of Acute Radiation-Induced Esophagitis.
    Lin MQ; Wu YH; Yang J; Lin HC; Liu LY; Yu YL; Yao QW; Li JC
    Front Microbiol; 2022; 13():883650. PubMed ID: 35756007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Gut Microbiota of Healthy Chilean Subjects Reveals a High Abundance of the Phylum Verrucomicrobia.
    Fujio-Vejar S; Vasquez Y; Morales P; Magne F; Vera-Wolf P; Ugalde JA; Navarrete P; Gotteland M
    Front Microbiol; 2017; 8():1221. PubMed ID: 28713349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinct shifts in the oral microbiota are associated with the progression and aggravation of mucositis during radiotherapy.
    Hou J; Zheng H; Li P; Liu H; Zhou H; Yang X
    Radiother Oncol; 2018 Oct; 129(1):44-51. PubMed ID: 29735410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gut microbiome predicts gastrointestinal toxicity outcomes from chemoradiation therapy in patients with head and neck squamous cell carcinoma.
    Hes C; Desilets A; Tonneau M; El Ouarzadi O; De Figueiredo Sousa M; Bahig H; Filion É; Nguyen-Tan PF; Christopoulos A; Benlaïfaoui M; Derosa L; Alves Costa Silva C; Ponce M; Malo J; Belkad W; Charpentier D; Aubin F; Hamilou Z; Jamal R; Messaoudene M; Soulières D; Routy B
    Oral Oncol; 2024 Jan; 148():106623. PubMed ID: 38006691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Potential Effect of Oral Microbiota in the Prediction of Mucositis During Radiotherapy for Nasopharyngeal Carcinoma.
    Zhu XX; Yang XJ; Chao YL; Zheng HM; Sheng HF; Liu HY; He Y; Zhou HW
    EBioMedicine; 2017 Apr; 18():23-31. PubMed ID: 28216066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of concomitant chemoradiation in locally advanced head and neck cancers.
    Lasrado S; Moras K; Pinto GJ; Bhat M; Hegde S; Sathian B; Luis NA
    Asian Pac J Cancer Prev; 2014; 15(10):4147-52. PubMed ID: 24935361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Initial analysis of the synergy of programmed cell death-1 (PD-1) inhibitor and concurrent chemoradiotherapy treatment for recurrent/metastatic head and neck squamous cell carcinoma patients.
    Li L; Chen L; Yan L; Guo Y; Li F; Fan M; Lan M; Lai X; Zhou J; Huang Y; Xu P; Lang J; Feng M
    Radiat Oncol; 2023 Jul; 18(1):109. PubMed ID: 37403098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral mucositis prevention by low-level laser therapy in head-and-neck cancer patients undergoing concurrent chemoradiotherapy: a phase III randomized study.
    Gouvêa de Lima A; Villar RC; de Castro G; Antequera R; Gil E; Rosalmeida MC; Federico MH; Snitcovsky IM
    Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):270-5. PubMed ID: 21163585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase III trial of low-level laser therapy to prevent oral mucositis in head and neck cancer patients treated with concurrent chemoradiation.
    Antunes HS; Herchenhorn D; Small IA; Araújo CM; Viégas CM; Cabral E; Rampini MP; Rodrigues PC; Silva TG; Ferreira EM; Dias FL; Ferreira CG
    Radiother Oncol; 2013 Nov; 109(2):297-302. PubMed ID: 24044799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Helminth infections and gut microbiota - a feline perspective.
    Duarte AM; Jenkins TP; Latrofa MS; Giannelli A; Papadopoulos E; de Carvalho LM; Nolan MJ; Otranto D; Cantacessi C
    Parasit Vectors; 2016 Dec; 9(1):625. PubMed ID: 27912797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multicenter prospective phase II trial of concurrent chemoradiotherapy with weekly low-dose carboplatin for cisplatin-ineligible patients with advanced head and neck squamous cell carcinoma.
    Ueki Y; Ohshima S; Yokoyama Y; Takahashi T; Shodo R; Yamazaki K; Ohtaki K; Saijo K; Tanaka R; Togashi T; Sato Y; Takano S; Omata J; Takahashi N; Okabe R; Horii A
    Int J Clin Oncol; 2024 Jan; 29(1):20-26. PubMed ID: 37843751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altitude-adaption of gut microbiota in Tibetan chicken.
    Du X; Li F; Kong F; Cui Z; Li D; Wang Y; Zhu Q; Shu G; Tian Y; Zhang Y; Zhao X
    Poult Sci; 2022 Sep; 101(9):101998. PubMed ID: 35841636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral microbiome and onset of oral mucositis in patients with squamous cell carcinoma of the head and neck.
    Reyes-Gibby CC; Wang J; Zhang L; Peterson CB; Do KA; Jenq RR; Shelburne S; Shah DP; Chambers MS; Hanna EY; Yeung SJ; Shete S
    Cancer; 2020 Dec; 126(23):5124-5136. PubMed ID: 32888342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness of low-level laser therapy (LLLT) in head and neck cancer patients receiving concurrent chemoradiation.
    Antunes HS; Schluckebier LF; Herchenhorn D; Small IA; Araújo CM; Viégas CM; Rampini MP; Ferreira EM; Dias FL; Teich V; Teich N; Ferreira CG
    Oral Oncol; 2016 Jan; 52():85-90. PubMed ID: 26559740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conventional radiotherapy versus concurrent chemoradiotherapy versus accelerated radiotherapy in locoregionally advanced carcinoma of head and neck: Results of a prospective randomized trial.
    Ghosh-Laskar S; Kalyani N; Gupta T; Budrukkar A; Murthy V; Sengar M; Chaukar D; Pai P; Chaturvedi P; D'Cruz A; Agarwal J
    Head Neck; 2016 Feb; 38(2):202-7. PubMed ID: 25224814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinctive microbiota of delayed healing of oral mucositis after radiotherapy of nasopharyngeal carcinoma.
    Jiang R; Liu Y; Zhang H; Chen Y; Liu T; Zeng J; Nie E; Chen S; Tan J
    Front Cell Infect Microbiol; 2022; 12():1070322. PubMed ID: 36605128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.